PRAME 300–309 (HLA-A*02:01)

PRAME 300–309 (HLA-A*02:01)
€50.00 *

Prices plus VAT plus shipping costs

Delivery time 3 weeks
sterile and endotoxin free Delivery Format:
The product is supplied freeze dried as trifluoracetate salt

Amount in mg:

make your choice

  • EP11397_1
ALYVDSLFFL is a linear peptidic epitope (epitope ID225231) studied as part of Melanoma antigen... more
Product information "PRAME 300–309 (HLA-A*02:01)"
ALYVDSLFFL is a linear peptidic epitope (epitope ID225231) studied as part of Melanoma antigen preferentially expressed in tumors from Homo sapiens (human), tested in T cell assays. Antigen Peptide PRAME 300–309 (HLA-A*02:01) ALYVDSLFFL for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

 
Sequence:ALYVDSLFFL
Gene:PRAME
Delivery: 3 weeks
C-Terminus:OH
N-Terminus:H
Purity:95%
Amount:1 mg
Counter Ion:TFA
Protein:Melanoma antigen preferentially expressed in tumors
Species:Human
Allele:HLA-A*02:01
Application :Flow Cytometry
Indication :Cancer
Dokumente - Protokolle - Downloads more
Viewed